Market Overview

DuPont's Industrial Biosciences Unit to Buy Verdezyen's Xylose Isomerase Technology

Share:
Related DD
DuPont Unit The Chemours Co. Announces Eight Individuals Elected to Board Following Spinoff
Nelson Peltz Is A Consistent Man: A Look At His Almost Unchanged Q1 Portfolio
DuPont: After The Defeat Of An Activist Investor, Insiders Continue To Buy (Seeking Alpha)

Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals, announced the sale of its proprietary xylose isomerase technology, enabling the metabolism of 5-carbon sugars, to DuPont Industrial Biosciences, a world leader in science and innovation.

Under the terms of the sale, DuPont has purchased rights to Verdezyne's patented xylose isomerase technology, covered by U.S. Patent Nos. 8,114,974 and 8,093,037, for use in the rapidly-commercializing biofuels and biochemical fields. This technology allows the fast and complete utilization of biomass-sourced C5 sugars in production of various products of choice. This technological breakthrough was highlighted in a recent Journal of Industrial Microbiology & Biotechnology article published August 2012.

Posted-In: News M&A

 

Related Articles (DD)

Around the Web, We're Loving...